Microdialysis and Pharmacokinetic Study of TR-701
NCT00666601
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
TR-700 (active moiety)
DRUG:
TR-701 (pro-drug)
Sponsor
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)